As shown in Supplementary Fig. 7d, MMP16-KD using 3 different shRNAs resulted in a significant reduction in MMP16 protein levels in DCIS.COM cells and showed consistent inhibition of invasion in vitro (data not shown). This evidence concerns the gene MMP16 and ductal breast carcinoma in situ.